Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Xiang-Yi Kong · SciRah

Researcher profile · Semantic Scholar

Xiang-Yi Kong

Share profile

Xiang-Yi Kong — researcher profile on SciRah

h-index: 32
Works: 163
Citations: 3,751

Most-cited papers

Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
Yong-Xiang Xia, Wei-Wei Tang, X. Qian, Xiangcheng Li +27 more
2022Journal for ImmunoTherapy of Cancer213 citations Open access
Semantic Scholar
Advances of medical nanorobots for future cancer treatments
Xiang-Yi Kong, Peng Gao, Jing Wang, Yi Fang +1 more
2023Journal of Hematology & Oncology178 citations Open access
Semantic Scholar
Nanoparticle Drug Delivery Systems and Their Applications as Targeted Therapies for Triple Negative Breast Cancer
Xiang-Yi Kong, Yi-Hang Qi, Xiang-Yu Wang, Rui Jiang +4 more
2023Progress in Materials Science140 citations
Semantic Scholar
Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
Xiaopei Hao, Guang-Shun Sun, Yao-Yao Zhang, Xiang-Yi Kong +4 more
2021Frontiers in Cell and Developmental Biology137 citations Open access
Semantic Scholar
Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
Li Chen, P. Bai, Xiang-Yi Kong, Shaolong Huang +4 more
2021Frontiers in Cell and Developmental Biology113 citations Open access
Semantic Scholar
Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy
Li Chen, Xiang-Yi Kong, Zhong-Zhao Wang, Xiang-Yu Wang +2 more
2020Journal of Cellular and Molecular Medicine86 citations Open access
Semantic Scholar
Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications
Xiang-Yi Kong, Ran Cheng, Jing Wang, Yi Fang +1 more
202177 citations
Semantic Scholar
Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015
Xiang-Yi Kong, Zhiqiang Liu, Ran Cheng, Li Sun +3 more
2020JAMA Network Open71 citations Open access
Semantic Scholar
LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1
Bolun Ai, Xiang-Yi Kong, Xiang-Yu Wang, Kai Zhang +7 more
2019Cell Death and Disease65 citations Open access
Semantic Scholar
Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
Li Chen, Xiang-Yi Kong, Zhong-Zhao Wang, Xiang-Yu Wang +2 more
2020Cancer Management and Research60 citations Open access
Semantic Scholar
The Research Progress on the Prognostic Value of the Common Hematological Parameters in Peripheral Venous Blood in Breast Cancer
Li Chen, Xiang-Yi Kong, Chengrui Yan, Yi Fang +1 more
2020OncoTargets and Therapy59 citations Open access
Semantic Scholar
Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer
Qiang Liu, J. Zhai, Xiang-Yi Kong, Xiang-Yu Wang +3 more
2020Molecular Therapy: Oncolytics56 citations Open access
Semantic Scholar
Multifunctional CuO/Cu2O Truncated Nanocubes as Trimodal Image-Guided Near-Infrared-III Photothermal Agents to Combat Multi-Drug-Resistant Lung Carcinoma.
Munusamy Shanmugam, Naresh Kuthala, Raviraj Vankayala, Chi-Shiun Chiang +2 more
2021ACS Nano54 citations
Semantic Scholar
Melatonin: A Potential Therapeutic Option for Breast Cancer
Xiang-Yi Kong, Ran Gao, Zhong-Zhao Wang, Xiang-Yu Wang +4 more
2020Trends in endocrinology and metabolism53 citations
Semantic Scholar
Artificial intelligence: a key to relieve China's insufficient and unequally-distributed medical resources.
Xiang-Yi Kong, Bolun Ai, Yi Kong, Lijuan Su +10 more
2019American journal of translational research49 citations
Semantic Scholar
Immunological therapy: A novel thriving area for triple-negative breast cancer treatment.
Xiang-Yu Wang, Yi-Hang Qi, Xiang-Yi Kong, J. Zhai +5 more
2019Cancer Letters45 citations
Semantic Scholar
Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples
Qiang Liu, Yi-Hang Qi, J. Zhai, Xiang-Yi Kong +4 more
2020Frontiers in Immunology42 citations Open access
Semantic Scholar
The Systemic Inflammation Response Index as an Independent Predictor of Survival in Breast Cancer Patients: A Retrospective Study
Meng-Liu Zhu, Li Chen, Xiang-Yi Kong, Xiang-Yu Wang +3 more
2022Frontiers in Molecular Biosciences40 citations Open access
Semantic Scholar
A systematic review: comparative analysis of the effects of propofol and sevoflurane on postoperative cognitive function in elderly patients with lung cancer
Hai-Tao Sun, Guo-Hua Zhang, Bolun Ai, Huimin Zhang +5 more
2019BMC Cancer40 citations Open access
Semantic Scholar
Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
Heng-Song Cao, Tian Huang, Mingrui Dai, Xiang-Yi Kong +8 more
2022International Journal on Biological Sciences37 citations Open access
Semantic Scholar
Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer
Li Chen, Xiang-Yi Kong, Yi Fang, Shishir Paunikar +5 more
2021Frontiers in Cell and Developmental Biology37 citations Open access
Semantic Scholar
PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases
Ke-Jun Zhang, Xiang-Yi Kong, Yuan Li, Zhong-Zhao Wang +2 more
2022Frontiers in Pharmacology33 citations Open access
Semantic Scholar
Research Progress Concerning Dual Blockade of Lymphocyte-Activation Gene 3 and Programmed Death-1/Programmed Death-1 Ligand-1 Blockade in Cancer Immunotherapy: Preclinical and Clinical Evidence of This Potentially More Effective Immunotherapy Strategy
Yi-Hang Qi, Li Chen, Qiang Liu, Xiang-Yi Kong +2 more
2021Frontiers in Immunology33 citations Open access
Semantic Scholar
Subsequent risk of suicide among 9,300,812 cancer survivors in US: A population-based cohort study covering 40 years of data
Qiang Liu, Xiang-Yu Wang, Xiang-Yi Kong, Zhong-Zhao Wang +5 more
2022EClinicalMedicine32 citations Open access
Semantic Scholar
Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
Li Chen, Yi-Hang Qi, Xiang-Yi Kong, Z. Su +6 more
2022Frontiers in Nutrition31 citations Open access
Semantic Scholar
Expression signatures and roles of microRNAs in inflammatory breast cancer
Yi-Hang Qi, Xiang-Yu Wang, Xiang-Yi Kong, J. Zhai +3 more
2019Cancer Cell International30 citations Open access
Semantic Scholar
A Systematic Study on Zinc-Related Metabolism in Breast Cancer
Zheng Qu, Qiang Liu, Xiang-Yi Kong, Xiang-Yu Wang +3 more
2023Nutrients29 citations Open access
Semantic Scholar
Toxicities associated with immune checkpoint inhibitors: a systematic study
Xiang-Yi Kong, Li Chen, Z. Su, R. Sullivan +8 more
2023International Journal of Surgery28 citations Open access
Semantic Scholar
PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential Mechanism
Hao Dong, Yi-Hang Qi, Xiang-Yi Kong, Zhong-Zhao Wang +2 more
2022Frontiers in Pharmacology28 citations Open access
Semantic Scholar
The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients
Meng-Liu Zhu, Li Chen, Xiang-Yi Kong, Xiang-Yu Wang +3 more
2022Cancer Management and Research27 citations Open access
Semantic Scholar
Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment
Yuan Li, Xiang-Yi Kong, L. Xuan, Zhong-Zhao Wang +1 more
2021Journal of Cellular and Molecular Medicine27 citations Open access
Semantic Scholar
Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment
Yuan Li, Xiang-Yi Kong, Zhong-Zhao Wang, L. Xuan
2022Journal of Cellular and Molecular Medicine24 citations Open access
Semantic Scholar
Mechanism of trastuzumab resistance caused by HER-2 mutation in breast carcinomas
Xiang-Yi Kong, Kai Zhang, Xiang-Yu Wang, Xue Yang +8 more
2019Cancer Management and Research24 citations Open access
Semantic Scholar
Clinicopathological characteristics of HER2-low breast cancer: a retrospective study
Man Yang, Jiale Sun, Li-Qiong Liu, Xiang-Yi Kong +3 more
2023Scientific Reports23 citations Open access
Semantic Scholar
Combined Gadolinium and Boron Neutron Capture Therapies for Eradication of Head-and-Neck Tumor Using Gd10B6 Nanoparticles under MRI/CT Image Guidance
Munusamy Shanmugam, Naresh Kuthala, Xiang-Yi Kong, Chi-Shiun Chiang +1 more
2023JACS Au23 citations Open access
Semantic Scholar
Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence
Yi-Hang Qi, Lin Zhang, Zhong-Zhao Wang, Xiang-Yi Kong +3 more
2021Frontiers in Pharmacology23 citations Open access
Semantic Scholar
Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
Wen-Xiang Zhang, Xiang-Yi Kong, Bolun Ai, Zhong-Zhao Wang +5 more
2021Frontiers in Oncology22 citations Open access
Semantic Scholar
Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data
Qiang Liu, Ran Cheng, Xiang-Yi Kong, Zhong-Zhao Wang +2 more
2020Frontiers in Immunology22 citations Open access
Semantic Scholar
Incidence, risk factors, prevention and treatment of postmastectomy pain syndrome in breast cancer: A multicenter study.
Yinpeng Ren, Xiang-Yi Kong, Qin-Heng Yang, Li Ouyang +5 more
2022International Journal of Surgery20 citations Open access
Semantic Scholar
Identification of the Significant Genes Regulated by Estrogen Receptor in Estrogen Receptor-Positive Breast Cancer and Their Expression Pattern Changes When Tamoxifen or Fulvestrant Resistance Occurs
Ran Cheng, Li-Qiang Qi, Xiang-Yi Kong, Zhong-Zhao Wang +2 more
2020Frontiers in Genetics20 citations Open access
Semantic Scholar
AGR2: a secreted protein worthy of attention in diagnosis and treatment of breast cancer
Ke-fei Zhang, Yuan Li, Xiang-Yi Kong, Chuqi Lei +5 more
2023Frontiers in Oncology18 citations Open access
Semantic Scholar
Clinical Features and Prognoses of Patients With Breast Cancer Who Underwent Surgery
Gang Liu, Xiang-Yi Kong, Qi-Chen Dai, Han Cheng +3 more
2023JAMA Network Open18 citations Open access
Semantic Scholar
A meta-analysis of 37 studies on the effectiveness of microsurgical techniques for lymphedema.
Xiang-Yi Kong, Jianshi Du, Xianlong Du, Xianling Cong +1 more
2022Annals of Vascular Surgery18 citations Open access
Semantic Scholar
Treatment of patients with cancer using PD-1/PD-L1 antibodies: Adverse effects and management strategies (Review)
Guang-Shun Sun, Hanyuan Liu, Xuesong Shi, Pengyu Tan +8 more
2022International Journal of Oncology18 citations Open access
Semantic Scholar
Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data
Xiang-Yi Kong, Yi-Hang Qi, Junjie Huang, Yang Zhao +11 more
2021Cancer Letters18 citations Open access
Semantic Scholar
Constructing an automatic diagnosis and severity-classification model for acromegaly using facial photographs by deep learning
Yan-Guo Kong, Xiang-Yi Kong, Cheng He, Changsong Liu +5 more
2020Journal of Hematology & Oncology18 citations Open access
Semantic Scholar
Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma
Xiang-Yi Kong, Zhiying Zheng, Guo-Xin Song, Zihao Zhang +10 more
2022Frontiers in Immunology17 citations Open access
Semantic Scholar
Oncotype DX Breast Recurrence Score Distribution and Chemotherapy Benefit Among Women of Different Age Groups With HR-Positive, HER2-Negative, Node-Negative Breast Cancer in the SEER Database
Ran Cheng, Xiang-Yi Kong, Xiang-Yu Wang, Yi Fang +1 more
2020Frontiers in Oncology17 citations Open access
Semantic Scholar
Revolutionizing the battle against locally advanced breast cancer: A comprehensive insight into neoadjuvant radiotherapy
Xiang-Yi Kong, Jiarui Song, Peng Gao, Ran Gao +5 more
2023Medicinal research reviews (Print)16 citations
Semantic Scholar
Molecular and Clinical Characterization of CCT2 Expression and Prognosis via Large-Scale Transcriptome Profile of Breast Cancer
Qiang Liu, Yi-Hang Qi, Xiang-Yi Kong, Xiang-Yu Wang +5 more
2021Frontiers in Oncology16 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Jing Wang×34
Invite
Jing Wang — researcher profile on SciRah
Yi Fang×34
Invite
Yi Fang — researcher profile on SciRah
Xiang-Yu Wang×20
Invite
Xiang-Yu Wang — researcher profile on SciRah
Zhong-Zhao Wang×20
Invite
Zhong-Zhao Wang — researcher profile on SciRah

×12

Invite

Yi-Hang Qi — researcher profile on SciRah

Invite

Li Chen — researcher profile on SciRah

Invite

J. Zhai — researcher profile on SciRah

Invite

Qiang Liu — researcher profile on SciRah

Invite

Ran Cheng — researcher profile on SciRah

Wei-Wei Tang×5

Invite

Wei-Wei Tang — researcher profile on SciRah

Invite

Ji-dong Gao — researcher profile on SciRah

Invite

Hanyuan Liu — researcher profile on SciRah